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.2012.07.0Abstract This work aimed to evaluate the analgesic efﬁcacy of intra-articular injection of magne-
sium sulphate (4%) compared with equivalent volume of bupivacaine (0.5%) after outpatient knee
arthroscopic meniscectomy. Forty patients were randomly assigned to two groups. Group M
(n= 20) received intra-articular magnesium sulphate 4%, group B (n= 20) received bupivacaine
(0.5%). Analgesic effect was evaluated by analgesic duration, and by measuring pain intensity at
1, 2, 4, 6, 12, 24 h both at rest and on knee movement to 90. The primary outcome variable
was pain intensity on the VAS at 1, 2, 4, 6, 12, 24 h post arthroscopy at rest and on movement (ﬂex-
ion of knee to 90), although the magnesium group had lower time weighted averages (TWAs) at
rest and on movement, these TWAs were not statistically signiﬁcant. The median duration of post-
operative analgesia was signiﬁcantly longer in the patients treated with magnesium sulphate
(528 min) than in the bupivacaine group (317 min) (p< 0.0001), with less number of patients need-
ing supplementary analgesia in magnesium group (8/20) than those of the bupivacaine group (16/
20) (p< 0.022). Also analgesic consumption was signiﬁcantly lower in the magnesium sulphate
group (p< 0.002). We concluded that the use of magnesium sulphate is rational and effective in
reducing pain, and is more physiological and shortens convalescence after outpatient arthroscopic
meniscectomy, however our hypotheses that analgesic efﬁcacy of intra-articular isotonic magnesium
sulphate would be superior to intra-articular local anaesthetic cannot be supported with this study.
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01Introduction
Knee arthroscopy is a common orthopedic practice usually
performed on an outpatient basis [1]. Arthroscopy has spared
patients from large incisions and decreased morbidity com-
pared with those of open procedures, but it has not eliminated
pain [2]. One of the most important aspects to be considered is.V. All rights reserved.
356 Y.A. Radwan et al.that the patients, who will be discharged shortly after surgery,
must be provided with an analgesic treatment that is both
effective and safe [3].
Most of the intra-articular structures of the knee including
the synovial tissue, the anterior fat pad and the joint capsule,
have free nerve-endings that are capable of sensing painful
stimuli and producing severe pain [4,5].
Previous studies [1,3,6–18] have investigated a wide variety
of intra-articular local anaesthetics, opioids and systemic non-
steroidal anti inﬂammatory drugs (NSAIDs). Intra-articular
(IA) local anaesthetics are often used for control of pain after
arthroscopic knee surgery due to their direct blockade of the
nociceptive pain response at the site of administration, with
minimal systemic absorption. However the mean duration of
analgesia provided by local anaesthetics is short and patients
may need supplementary analgesia, possibly delaying patient
discharge. To overcome this, the search continues for various
drugs looking for an ideal analgesic technique which is site-
speciﬁc, long lasting, easily administered and has a high ther-
apeutic index with minimal adverse reactions [9].
A relatively new approach for peripheral pain control is to
use magnesium sulphate. Magnesium has been investigated as
an adjuvant agent for intra- and postoperative analgesia as it
can block calcium inﬂux and non-competitively antagonize
N-methyl D-aspartate (NMDA) receptor channels [19]. Mag-
nesium sulphate has been used successfully to potentiate opi-
oid analgesia; this encouraged its use after major lumbar
orthopedic surgery [20]. Recent studies have found that in-
tra-articular injection of magnesium sulphate is effective for
postoperative analgesia when compared with saline (control)
in arthroscopic knee surgery [10,15].
The present investigation should help to test an acceptable,
effective alternative intra-articular analgesic with a long dura-
tion of analgesia after knee arthroscopic menisectomy and to
introduce some modiﬁcation to minimize the risk of potential
chondrocyte damage from previous suggested concentrations.
Our aim was to evaluate the analgesic efﬁcacy of intra-artic-
ular injection of magnesium sulphate 4% compared with
equivalent volume of bupivacaine (0.5%) after knee arthro-
scopic menisectomy. Our hypotheses was that analgesic efﬁ-
cacy of intra-articular isotonic magnesium sulphate would be
superior to intra-articular local anaesthetic.
Patients and method
We carried out a prospective randomized and double blinded
study. A total of 40 adult consecutive patients who had been
diagnosed with torn meniscus and were candidates to arthro-
scopic menisectomy with American Society of Anaesthesiolo-
gists (ASA) physical status physical status classes I and II
were included in the study, after obtaining hospital ethics com-
mittee approval, and informed written consents.
Exclusion criteria comprised patients who were on chronic
use of NSAID, opiates, calcium channel blockers, corticoste-
roids, tricyclic antidepressant, or in the presence of psychiatric
disorders, history of gastric or duodenal ulcers, hypersensitiv-
ity to NSAIDs, consumption of analgesics within 24 h of sur-
gery, pregnancy, breast-feeding, liver or renal disease, or
hypersensitivity to local anaesthesia.
Before the operation, all patients received detailed instruc-
tions for using a 100-mm Visual Analogue Scale (VAS) score
with 0 = no pain, to 100 = the worst imaginable pain.Patients were randomized using a random number genera-
tor to one of the following regimens: group M (n= 20) re-
ceived 20 ml of magnesium sulphate 4% (800 mg; 8 ml of
magnesium sulphate 10% and 12 ml of distilled water, Osmo-
larity is 320 mOsm/L), and group B (n= 20) received 20 ml
0.5% bupivacaine after completion of arthroscopy and
10 min prior to tourniquet release. An independent anaesthesi-
ologist who did not participate in the study prepared the study
medication.
Anaesthetic regimen
Induction of anaesthesia was achieved by fentanyl 1 lg kg1,
propofol 2 mg kg1, and atracurium 0.5 mg kg1. Endotracheal
intubation was performed and mechanical ventilation was ap-
plied. Anaesthesia was maintained by sevoﬂurane 1% in a gas
mixture of oxygen (40%) and nitrous oxide (60%). Depth of
anaesthesia was maintained by increasing or decreasing sevoﬂu-
rane percentage taking hemodynamic changes as indicators.
At conclusion of surgery, inhalation anaesthetics were dis-
continued and muscle relaxant was reversed by neostigmine
sulphate 0.05 mg kg1 and atropine sulphate 0.02 mg kg1.
There were no complications related to anaesthesia or analge-
sic used.
Surgical procedure
Once the patient had been anaesthetized, the tourniquet was
inﬂated, the surgical ﬁeld was sterilized, and a standard
arthroscopy technique was performed through an anterolateral
and anteromedial portal. Partial meniscectomy was performed.
The respective drug was injected into the joint after the portals
had been stitched to prevent extravasation at the end of sur-
gery, 10 min before tourniquet deﬂation and this was taken
as the start time of the study. A compression bandage was ap-
plied, and the tourniquet was removed.
Pain assessment
The primary outcome measure (post-arthroscopy pain) was as-
sessed at rest and on movement of the knee to 90 by visual
analogue pain score (VAS) as 0 mm is no pain and 100 mm
is worst imaginable pain. A rescue dose of tramadol 50 mg
intravenously was available as a postoperative analgesia at
the patient’s request or when the VAS value was higher than
40. The patients were discharged if they met home-readiness
criteria that included orientation to time and place, stable vital
signs, absence of nausea and vomiting, adequate control of
pain, and ability to void and ambulate. Discharge time was
classiﬁed as the time from the end of surgery until the patients
met the discharge criteria. On discharge, patients were given
diclofenac 50 mg tablets to be taken if needed.
The following parameters were recorded
Age, sex, weight, ASA status, and duration of surgical proce-
dure (tourniquet time), were recorded.
Pain was recorded by the patients as they were given a data
sheet and were asked to rate their pain intensity on the VAS at
1, 2, 4, 6, 12, 24 h post arthroscopy at rest and on movement
(ﬂexion of knee to 90), Finally, the patient recorded VAS
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downstairs after 24 h from the arthroscopy.
The time of ﬁrst patient need for analgesia (duration of
postoperative analgesia) was measured from time of comple-
tion of surgery until ﬁrst requirement of analgesic (Rescue
Dose). After discharge, Patients were asked to record when
they needed the ﬁrst analgesic, also they were asked to record
if they needed supplementary analgesia and the total amount
of oral diclofenac consumption in the subsequent 24 h, and
presence of any undesirable effects.
Finally the presence of knee effusion at the 10th day, time
to return to work and time to become pain free were recorded.
Statistical analysis
Data were analyzed using computer statistical software system
STATA version 9. Continuous variables were tested for nor-
mality. The baseline participants’ characteristics information,
duration of surgical procedure, and discharge time analgesic
duration were analyzed using two-tailed unpaired t-tests. Gen-
der distribution was compared using Fisher’s exact test. Be-
tween group differences in pain scores were analyzed by
unpaired t test (primary outcome measure). The time weighted
averages (TWAs) of the visual analogue scale at rest and on
movement were calculated. The calculation was made by plot-
ting the pain scores of the two compared groups across time
(1 h till 24 h) then the Area-Under-the-Curves (AUCs) for
the two groups were computed. t-Test was utilized to compare
the TWAs.
The need for analgesia was compared using Fisher’s exact
test. Multiple secondary outcome measures included the total
diclofenac consumption, and analgesic duration were not nor-
mally distributed, hence Mann–Whitney U-test was used to
compare this variable across the two groups. Descriptive data
were expressed as mean (SD), median (25–75th percentiles), or
participants number (%). Sample size was estimated using pain
scores as the primary variable. Assuming a SD of 10 mm, the
minimum needed sample size to detect a difference of 10 mm
on the VAS at an alpha threshold of 0.05 with 80% power is
34. So each group should include at least 17 patients. There-
fore, we included 20 patients per group.
Results
All 40 patients completed the study; Patient characteristics are
presented in (Table 1). There were no statistical differences be-
tween both groups in terms of age, weight, ASA status, gender,
tourniquet time and pre arthroscopy VAS at rest and on knee
movement (Table 1).Table 1 The baseline characteristics of the magnesium (M) group a
Group M (n= 20)
Age (y) 31.10 (7.90)
Weight (kg) 82.00 (8.10)
Surgery Duration (min) 45.80 (9.98)
Male 17 (85.00%)
ASA I/ASA II 15/5
Pre VAS at rest (mm) 11.70 (4.52)
Pre VAS on movement (mm) 15.50 (5.71)
Values are mean (SD) or number (%).Although the VAS values (both at rest and on knee move-
ment to 90) of the patients treated with magnesium sulphate
tended to be lower than those of the bupivacaine group, the
differences were not statistically signiﬁcant (Table 2). Magne-
sium group had lower time weighted averages (TWAs) at rest
and on movement, these TWAs were not statistically signiﬁ-
cant (Table 3).
The median duration of postoperative analgesia (range)
was signiﬁcantly longer in the patients who received magne-
sium sulphate 528 (480–570) min than in the patients in bupiv-
acaine group 317 (223–371) min (p< 0.0001) Fig. 1.
None of the patients in the magnesium sulphate group
needed analgesia during hospital stay before discharge, but
(6/20) patients in bupivacaine group needed analgesia
(p= 0.02).
The participants who took magnesium sulphate were less
likely to take postoperative additional oral analgesia in the
next 24 h after the arthroscopy (8/20) than those of the bupiv-
acaine group (16/20) [Fisher’s Exact test p= 0.022 RR = 0.50
(95% CI = 0.280–0.893)]. Also total median oral diclofenac
consumption was signiﬁcantly lower in the magnesium sul-
phate group 0 (0–87.5) mg than in bupivacaine group 100
(50–150) mg (p= 0.002) (Table 4).
Hospital stay averaged 4.5 h, and discharge time was not
different between magnesium group (264 min ± 17) and
bupivacaine group (271 ± 24 min) (p= 0.279). There was no
signiﬁcant difference between both groups regarding pain at
leg lift 10 times or at walking stairs at 24 h, also at time to be-
come pain free and time to return to work, although the values
tend to be lower in the magnesium sulphate group (Table 5).
Only one patient in each group developed knee effusion that
was resolved within 1 week. We reported no need for hospital
re-admission after discharge and no side effects related to in-
tra-articular injection in both groups.
Discussion
The principal ﬁnding of this investigation is that there was no
signiﬁcant difference between the two groups as regards the
primary outcome measure (postoperative pain scores) between
both groups, however, analysis of the secondary outcome mea-
sures showed that intra-articular administration of magnesium
sulphate (4%, 800 mg; 8 ml of magnesium sulphate 10% and
12 ml of distilled water, Osmolarity is 320 mOsm/L) at the
end of arthroscopic menisectomy is more effective than in-
tra-articular bupivacaine as evidenced by a signiﬁcantly longer
analgesic duration in the magnesium sulphate group (528) min
than in the patients in bupivacaine group (317) min. The par-
ticipants who took magnesium sulphate were less likely to takend bupivacaine (B) group.
Group B (n= 20) p Value
32.20 (9.62) 0.70
80.15 (8.60) 0.49
45.40 (11.03) 0.91
18 (90.00%) 1.00
16/4 1.00
10.30 (3.93) 0.44
15.00 (4.30) 0.80
Table 2 Comparison of the resting VAS and VAS on knee movement to 90 across the groups at the different time periods.
VAS at rest VAS with knee movement to 90
1 h 2 h 4 h 6 h 12 h 24 h 1 h 2 h 4 h 6 h 12 h 24 h
Group M
(n= 20)
19.05
(7.00)
16.55
(6.13)
16.35
(6.58)
15.80
(6.36)
20.65
(7.56)
24.40
(10.89)
26.35
(7.06)
22.85
(6.18)
21.35
(6.10)
21.30
(6.13)
25.10
(7.51)
28.10
(13.67)
Group B
(n= 20)
21.80
(7.89)
17.80
(7.37)
17.30
(3.28)
18.00
(4.72)
24.25
(8.26)
28.05
(13.74)
30.60
(6.47)
23.80
(5.20)
24.20
(7.00)
22.80
(5.16)
31.50
(11.83)
34.95
(15.70)
pa Value 0.25 0.60 0.60 0.22 0.19 0.36 0.06 0.60 0.20 0.41 0.07 0.23
Values are mean (SD).
a Bonferroni adjustment was used.
Table 3 Comparison of the time weighted averages (TWAs) of the visual analogue scale at rest and on movement across the groups.
Group (M) TWA (SD) Group (B) TWA (SD) p Value
VAS at rest 24.77 (06.72) 29.55 (08.94) 0.09
VAS on movement 19.84 (06.24) 22.77 (06.83) 0.22
Fig. 1 The analgesic duration in minutes in the both groups. The
box represents the 25–75th percentiles, and the median is
represented by the solid line. The extended bars represent two
standard deviation. Magnesium group had a signiﬁcantly longer
time to ﬁrst analgesic request (rescue dose) than bupivacaine
group (p< 0.0001).
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the arthroscopy (8/20) than those of the bupivacaine group
(16/20), ﬁnally magnesium sulphate group participants re-
quired signiﬁcantly lower dose of supplementary analgesia in
the ﬁrst 24 h after surgery than in bupivacaine group, which
may be explained by the more prolonged action of magnesium.
The absence of statistically signiﬁcant differences between
both groups in measures of pain (VAS at rest, VAS on move-
ment and time to return to work and time to become pain free)
may be explained by the availability of analgesia on demand
which may lead to a converging of pain scores, as differences
in pain are translated into differences in behaviour and analge-
sic consumption.
Evaluation of the level of postoperative pain in a relatively
minor arthroscopic surgery with an expected mild pain is difﬁ-
cult. The most commonly accepted method is the Visual Ana-
logue Scale VAS for assessing analgesia and the need to take
additional analgesics as a rescue dose [3,7,9–10,13,18]. Various
factors have been implicated in pain after arthroscopy and the
effectiveness of intra-artiular analgesia. These include preopera-
tive pain scores, duration of anaesthesia, type of surgery, volume
injected, time of intra-articular injection relative to tourniquet
deﬂation, pain assessment in rest and movement, whether the
study performed as an outpatient case or not. All these factors
make the large number of studies difﬁcult to compare [12].
In the design of this study we attempted to use best practice
in performance and analysis, as the comparison of VAS at rest
and on knee movements, by stressing the joint, the degree of
pain and adequacy of analgesia are better assessed. Such test-
ing has been recommended for the assessment of postoperative
pain, especially when assessing outpatients for discharge home
[7,12,17–18]. Neuroaxial block can affect the pain scores in the
early postoperative time so we used general anaesthesia with
endotracheal intubation with short acting anaesthetic duration
(propofol, fentanyl, sevoﬂurane and N2O), with which the pa-
tients became fully conscious within 30 min after recovery
from anaesthesia.
Also we released the tourniquet 10 min after intra-articular
injection, as this confounding variable may affect the analgesicefﬁcacy of intra-articular substance as noticed by Whitford et
al. [21] who observed that keeping the tourniquet inﬂated for
10 min provided superior analgesia and decreased the need
for supplementary analgesics compared with releasing the
tourniquet immediately after intra-articular injection. It is pos-
sible that by increasing the time-interval between intra-articu-
lar injection and tourniquet release, the local tissue-binding to
receptors can be increased, enhancing the analgesic effect.
Magnesium sulphate is a widely used drug with good safety
and efﬁcacy for many indications including eclampsia, cardiac
arrhythmias, acute severe asthma and perioperative as one of
the analgesic and opioid saving drug. Mg2+ preparations are
usually well tolerated even when given at large dosages and
are considered to be safe as reported by Koinig et al. [22]
who used magnesium sulphate 50 mg kg–1 intravenously and
Table 4 Comparison of the total postoperative analgesic intake across the groups.
Group M (n= 20) Group B (n= 20) p Value
Number of patients requiring analgesia at hospital 0a 6 (30%) 0.020
Number of patients requiring supplementary analgesia at home 8 (40%)a 16 (80%) 0.022
Diclofenac consumption (mg) 0b (0–87.5) 100 (50.0–150.0) 0.002
a No. (%).
b Median (25–75th percentiles).
Table 5 Comparison of hospital stay, pain at leg lift and walking, and the time to become pain free and time to return to work across
the groups.
Group (M) n= 20 Group (B) n= 20 p Value
Hospital stay (min) 264 (17) 271 (24) 0.28
Pain at leg lift 32.60 (13.48) 36.20 (13.32) 0.06
Pain at walking stairs 29.45 (12.90) 34.15 (12.58) 0.54
Time to become pain free (days) 5.60 (2.4) 7.50 (3.1) 0.07
Time to return to work (days) 10.70 (2.6) 12.70 (3.9) 0.06
Values are mean (SD).
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sium sulphate reduces intra- and postoperative analgesic
requirements without serious adverse reactions.
Experimental and clinical data from acute and chronic pain
situations demonstrate an effect of magnesium on the pain
threshold, which is clinically apparent postoperatively as a
reduction of analgesic requirements [22]. In our study, the
analgesic efﬁcacy of intra-articular magnesium sulphate is evi-
dent even after decreasing the osmolarity of the magnesium
sulphate solution to be nearly isotonic instead of the previous
work of Bondok and Abd El-Hady [10] who used hyperosmo-
lar solution (550 mOsm/L). This may prevent any potential
harmful effect of hyperosmolar solution on the cartilage or
nerve ﬁbres intra-articularly.
Patients in magnesium group did not need analgesic before
discharge, became pain free and returned home 1.9 days earlier
than patients in group bupivacine with less need for supple-
mentary analgesia is important and points to more effective
analgesic action of magnesium sulphate and that it extends
longer than the 24 h which was the limit of the study. Although
these differences were not statistically signiﬁcant, it may have a
relevant clinical signiﬁcance, this suggests further studies to
test its validity.
The current study has some limitations. First of all, the
plasma concentrations of the drugs were not measured and
chondrotoxic effects of the drugs were not tested however
study by Baker et al. [23] showed that magnesium sulphate ex-
erts a less toxic effect on monolayer chondrocyte culture than
local anaesthetic, they showed no signiﬁcant difference be-
tween the magnesium sulphate and normal saline treatments
suggesting that magnesium sulphate is no more detrimental
to chondrocyte viability than arthroscopic ﬂuid that may ex-
plain the earlier return to work. Second, the obtained results
are not generalizable since we use it in arthroscopic menisecto-
my only, and elderly and children were not included. Although
the analgesic effect of intra-articular magnesium sulphate is
proved; the debate is about the proper concentration and
osmolarity which needs further investigations to explore itseffect after arthroscopy. Finally, before translating the result
of this study into clinical practice, the possible side effects of
magnesium systemic absorption particularly in patients with
impaired renal function or high risk patients, should be consid-
ered carefully.Conclusion
The study ﬁndings indicate that following outpatient arthro-
scopic knee surgery, the use of magnesium sulphate is rational
and effective in reducing pain, and is more physiological and
shortens convalescence after outpatient arthroscopic meniscec-
tomy, however Our hypotheses that analgesic efﬁcacy of intra-
articular isotonic magnesium sulphate would be superior to in-
tra-articular local anaesthetic cannot be supported with this
study.
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